Treatment Strategies for a Rapidly Evolving Landscape in Chronic Lymphocytic Leukemia Management

Scientists address treatment duration and sequence considerations and discuss current targeted treatment dilemmas of chronic lymphocytic leukemia, where they review B cell lymphoma 2 inhibitors and Bruton’s tyrosine kinase in a fixed duration and continuous treatment manner.